论文部分内容阅读
目的分析急性呼吸窘迫综合征的临床治疗。方法回顾性分析2014年1月至2015年1月来院治疗的急性呼吸窘迫综合征患者26例的临床资料,分析其临床治疗方法和疗效。结果本组26例病例中治愈10例,死亡16例,死亡率为61.54%。结论应用血管扩张剂治疗急性呼吸窘迫综合征,可提高治疗效果,降低病死率,同时可减少合并多脏器功能衰竭综合征的发生,值得临床推广使用。
Objective To analyze the clinical treatment of acute respiratory distress syndrome. Methods The clinical data of 26 patients with acute respiratory distress syndrome who were hospitalized from January 2014 to January 2015 were analyzed retrospectively. The clinical treatment and efficacy were analyzed. Results The group of 26 cases were cured in 10 cases, 16 patients died, the mortality rate was 61.54%. Conclusion The application of vasodilator in the treatment of acute respiratory distress syndrome can improve the therapeutic effect, reduce the mortality and reduce the incidence of combined multiple organ failure syndrome, which is worthy of clinical promotion.